Member Info for Laura2022

From 10th July

Expansion of collaboration

Physiomics and DoseMe have recently signed non-binding Heads of Terms with the intention of expanding their partnership beyond the Company's current personalised dosing software. This agreement defines terms across four areas of collaboration:

· development and commercialisation of novel dosing software tools originating from Physiomics;

· development and commercialisation of novel dosing software tools originating from DoseMe or its clients;

· provision of consultancy services by the Company to DoseMe; and

· co-development of clinical trial dosing software in support of biopharmaceutical clients.

The two parties are actively working to identify potential projects falling under these umbrella categories and further announcements on this will be made when appropriate.

The PYC partner website has been down for about 24hrs

Be interesting to see what is being updated

https://doseme-rx.com/en-gb/why-dosemerx/drug-packages

Affc

Exactly that, gallium is the hidden gem here

Looks like the TR1s have been adding today

Wouldn't it be nice if people like him (amd others).simply used their time on shares they are invested.in

Have a good Halloween weekend Trench, KingH and other genuine shareholders

Trench

As we recall from summer Trout can never remember which of his lies are true

Including claiming he had a shareholding BELOW the share price , went silent on FAB for weeks as it climbed and he had got caught out trading it again...

He clearly has nothing better to do with 90% of his time than stalk this board

Tight spread again....and more block buys at 0.16

Current 0.153 to 0.16

Kingh

There's simply no point conversing...I realised that 3mths ago

He is hellbent....in fact..obsessed...with PYC whilst when asked simple questiosn about his holding /motivations on FAB PYC he couldn't give straight answers

Kingh

The MSA could well be the company you refer to

Interesting also was this post from Debull about the other UK Client for PYC

According to Grok "UK-based biotech client at the forefront of AI-driven drug development.” The 3 it lists are Benevolent AI, Exscientia and Healx

My goodness

Is Trout STILL here ??!!

Over 12mths probably spent 90% of his posts on PYC

Strange obsession

GDR 0.3p to 1.15p

POLX next ?

Very.kind of you to say that

After the 29th Sept results and presentation it stated

"6 late stage contracts due "

You would expect them to start to be announced in quick order just like the ones March to July which were mentioned in the March presentation

Quite why they needed emails from myself and others to stop the disastrous CLN is beyond me, but at least.done now

n light of the revised development plan and noting the adverse share price reaction since the Investment Agreement was entered into, the Company has entered into a Deed of Termination with the Investors whereby the Investment Agreement will terminate immediately following Admission and repayment of the unconverted element of the Advance, together with an early termination fee of 12% (the "Repayment").

Polx charts bottomed, block buying, should be a good blue day today

Quite what green boxes were doing posting on a share they dont own after 10.30pm is beyond most normal comprehension

1) Large holders (2 industry linked) make offer

2) continued orders from the other 19 USA states

3) BOD review.options properly

Thanks affc

Safi

Genuine holders who know what the actual prices were

Green box/filters won't know as they dont hold stock

The 10mln was a grey trade and was a buy at some point today

Looks good

Liz says the trial of the DoseMe technology at Redcliffe was a first in the Metro North Health.

“The trial is being led by a partnership with Pharmacy and the Infectious Diseases/Antimicrobial Stewardship team here at Redcliffe,” Liz said.

“It’s something that we know is being followed closely by other hospitals too, both in Queensland, across Australia, and internationally.”

Liz said the new technology used data and computer modelling combined with blood test results to determine the right dose for that patient.

Great news